February 27, 2020 / 8:39 AM / a month ago

BRIEF-Peptonic Medical Q4 Operating Loss Widens To SEK 11.5 Mln

Feb 27 (Reuters) - Peptonic Medical AB:

* Q4 NET SALES OF PRODUCTS SEK 394,000 (263,000)

* BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND IS PAID FOR FISCAL YEAR 2019

* Q4 OPERATING LOSS SEK 11.5 MILLION VERSUS LOSS SEK 4.6 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below